Lincoln National Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,608
| Closed | -$1.09M | – | 1103 |
|
|
2024
Q1 | $1.09M | Buy |
2,608
+548
| +27% | +$229K | 0.02% | 492 |
|
|
2023
Q4 | $838K | Buy |
2,060
+714
| +53% | +$291K | 0.01% | 507 |
|
|
2023
Q3 | $468K | Buy |
1,346
+154
| +13% | +$53.6K | 0.01% | 626 |
|
|
2023
Q2 | $419K | Sell |
1,192
-1,172
| -50% | -$412K | 0.01% | 666 |
|
|
2023
Q1 | $745K | Buy |
2,364
+34
| +1% | +$10.7K | 0.02% | 463 |
|
|
2022
Q4 | $673K | Buy |
2,330
+874
| +60% | +$252K | 0.02% | 456 |
|
|
2022
Q3 | $422K | Buy |
1,456
+101
| +7% | +$29.3K | 0.01% | 542 |
|
|
2022
Q2 | $382K | Buy |
1,355
+17
| +1% | +$4.79K | 0.01% | 560 |
|
|
2022
Q1 | $349K | Buy |
1,338
+68
| +5% | +$17.7K | 0.01% | 668 |
|
|
2021
Q4 | $278K | Sell |
1,270
-1
| -0.1% | -$219 | 0.01% | 737 |
|
|
2021
Q3 | $231K | Buy |
1,271
+246
| +24% | +$44.7K | 0.01% | 782 |
|
|
2021
Q2 | $206K | Buy |
+1,025
| New | +$206K | ﹤0.01% | 803 |
|